Cargando…

Screening a nation for hepatitis C virus elimination: a cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population

OBJECTIVES: We analysed data collected during programmatic screening activities conducted in 2017 to describe hepatitis C virus (HCV) seroprevalence in the general population and identify associated factors. DESIGN: We analysed data collected between June and September 2017. For both seroprevalence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umutesi, Justine, Liu, Carol Yingkai, Penkunas, Michael J, Makuza, Jean Damascene, Ntihabose, Corneille K, Umuraza, Sabine, Niyikora, Julienne, Serumondo, Janvier, Gupta, Neil, Nsanzimana, Sabin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615840/ https://www.ncbi.nlm.nih.gov/pubmed/31272986 http://dx.doi.org/10.1136/bmjopen-2019-029743

Ejemplares similares

Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators
por: Serumondo, Janvier, et al.
Publicado: (2020)

Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
por: Makuza, Jean Damascene, et al.
Publicado: (2019)

Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda
por: Makuza, Jean Damascene, et al.
Publicado: (2019)

Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study
por: Makuza, Jean Damascene, et al.
Publicado: (2020)

Controlling hepatitis C in Rwanda: a framework for a national response
por: Mbituyumuremyi, Aimable, et al.
Publicado: (2018)

Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach
por: Kamali, Innocent, et al.
Publicado: (2021)

Epidemiology of sexually transmitted infections: trends among patients screened for sexually transmitted infections in rwandan health facilities 2014–2020
por: Makuza, Jean Damascene, et al.
Publicado: (2022)

Cross-sectional study of chronic hepatitis B virus infection in Rwandan high-risk groups: unexpected findings on prevalence and its determinants
por: Umutesi, Justine, et al.
Publicado: (2021)

Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda
por: Umutesi, Justine, et al.
Publicado: (2017)

Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination
por: Lim, Aaron G, et al.
Publicado: (2018)

The Cascade of Care for Hepatitis C Treatment in Rwanda: A Retrospective Cohort Study of the 2017–2019 Mass Screening and Treatment Campaign
por: Nisingizwe, Marie Paul, et al.
Publicado: (2023)

Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting
por: Umutesi, Justine, et al.
Publicado: (2022)

Hepatitis C virus genotype analysis in patients with chronic hepatitis in North Eastern Bulgaria
por: Brady, Zarina, et al.
Publicado: (2019)

Prevalence of undiagnosed HIV, hepatitis B, and hepatitis C among patients in an Indian emergency department
por: Pandiselvam, Sathishkumar, et al.
Publicado: (2020)

Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study
por: Munyazesa, Elisaphane, et al.
Publicado: (2012)

For patients with rheumatic disease and hepatitis C infection: the end of interferon
por: Calabrese, Leonard H, et al.
Publicado: (2015)

Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections
por: Ayoub, Houssein H, et al.
Publicado: (2019)

Real-world Experiences in the Transplantation of Hepatitis C-NAAT–positive Organs
por: Steinbrink, Julie M., et al.
Publicado: (2023)

Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam–hepatitis C)
por: Rapoud, Delphine, et al.
Publicado: (2020)

Prevalence Rate of Hepatitis C Among the Solid Waste Handler in Wardha City
por: Wanjari, Mayur B, et al.
Publicado: (2021)

Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen
por: Trigg, Andrew, et al.
Publicado: (2019)

Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis
por: Bigna, Jean Joel, et al.
Publicado: (2017)

Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt
por: Ayoub, Houssein H, et al.
Publicado: (2020)

Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections
por: Stewart, Zoe A., et al.
Publicado: (2021)

Retrospective hepatitis C seroprevalence screening in the antenatal setting—should we be screening antenatal women?
por: Orkin, Chloe, et al.
Publicado: (2016)

Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection
por: Husson, Jennifer S., et al.
Publicado: (2017)

A surveillance for hepatitis C virus infection in northeastern, Thailand: a 10-year cohort
por: SUTTICHAIMONGKOL, TANITA, et al.
Publicado: (2022)

Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan
por: Ali, Syeda M, et al.
Publicado: (2023)

Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region
por: Chastain, Cody A., et al.
Publicado: (2022)

Multimodal Treatment of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antivirals
por: Mercan-Stanciu, Adriana, et al.
Publicado: (2022)

Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
por: Odhiambo, Raymond, et al.
Publicado: (2013)

Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users
por: van den Berg, Charlotte H. S. B., et al.
Publicado: (2007)

Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries
por: Falla, Abby M., et al.
Publicado: (2017)

Aligning an emergency department hepatitis C and human immunodeficiency virus testing quality improvement initiative with universal screening recommendations
por: Cave, Barbra, et al.
Publicado: (2022)

Drug-induced liver injury by glecaprevir/pibrentasvir treatment for chronic hepatitis C infection: a systematic review and meta-analysis
por: Hung, Hsuan-Yu, et al.
Publicado: (2021)

Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: a cross-sectional investigation in Taiwan
por: Lin, Ming-Shyan, et al.
Publicado: (2019)

A Proof of Concept Study Demonstrating the Feasibility of a Text Message Prompt for Hepatitis C Testing in the 1945-1965 Birth Cohort
por: Fisk, Rebecca J, et al.
Publicado: (2019)

Community engagement approaches for malaria prevention, control and elimination: a scoping review protocol
por: Awasthi, Kiran Raj, et al.
Publicado: (2021)

The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T’N’T HepC)
por: Lazarus, Jeffrey Victor, et al.
Publicado: (2020)

Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study
por: Kamali, Innocent, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9msm4e58j8kqrj392tlan6qjd9